Amalgamated Bank increased its position in Danaher Corporation (NYSE:DHR) by 58.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,858 shares of the conglomerate’s stock after buying an additional 25,372 shares during the period. Amalgamated Bank’s holdings in Danaher Corporation were worth $5,811,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Waldron LP purchased a new stake in Danaher Corporation during the first quarter valued at approximately $320,000. Empire Life Investments Inc. raised its position in Danaher Corporation by 2.3% during the first quarter. Empire Life Investments Inc. now owns 77,900 shares of the conglomerate’s stock valued at $6,662,000 after purchasing an additional 1,764 shares during the period. Destination Wealth Management raised its position in Danaher Corporation by 3.9% during the first quarter. Destination Wealth Management now owns 107,774 shares of the conglomerate’s stock valued at $9,218,000 after purchasing an additional 3,999 shares during the period. Karp Capital Management Corp purchased a new stake in Danaher Corporation during the first quarter valued at approximately $38,453,000. Finally, Sei Investments Co. raised its position in Danaher Corporation by 5.2% during the first quarter. Sei Investments Co. now owns 360,986 shares of the conglomerate’s stock valued at $30,876,000 after purchasing an additional 17,995 shares during the period. Institutional investors own 75.66% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Danaher Corporation (DHR) Shares Bought by Amalgamated Bank” was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/10/18/danaher-corporation-dhr-shares-bought-by-amalgamated-bank.html.

In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the sale, the insider now owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider William King sold 7,458 shares of the business’s stock in a transaction that occurred on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now directly owns 18,245 shares in the company, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. In the last three months, insiders sold 71,496 shares of company stock worth $5,916,223. 12.20% of the stock is owned by corporate insiders.

DHR has been the topic of a number of recent research reports. Zacks Investment Research downgraded Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Goldman Sachs Group, Inc. (The) restated a “neutral” rating and set a $83.00 price objective on shares of Danaher Corporation in a research report on Tuesday, September 26th. BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a research report on Friday, September 8th. Finally, Citigroup Inc. set a $96.00 price objective on Danaher Corporation and gave the company a “buy” rating in a research report on Friday, July 21st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. Danaher Corporation presently has an average rating of “Buy” and a consensus target price of $92.62.

Danaher Corporation (NYSE DHR) opened at 85.26 on Wednesday. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.62. The company has a market cap of $59.23 billion, a PE ratio of 27.21 and a beta of 1.03. The company has a 50-day moving average price of $85.95 and a 200 day moving average price of $84.19.

Danaher Corporation (NYSE:DHR) last announced its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. The company had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.90 earnings per share. On average, equities research analysts forecast that Danaher Corporation will post $3.96 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s payout ratio is 17.83%.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.